A new hospital supplies market report from GBI Research and Research and Markets says that growing concerns about hospital-acquired infections (HAIs) are driving the demand for disposable needles and syringes. The report states that demand for disposable hospital supplies is growing across the world, as they reduce risks of cross-contamination. The growing diabetes population and increasing numbers with access to state healthcare coverage mean that more and more patients will face the risk of infection through hospital contagion.
State healthcare systems are being pressured to impose active measures against HAIs, and their prevention, control and management have fueled the demand for single-use products. Governments in developed countries are encouraging the use of disposable hospital supplies in order to reduce healthcare costs incurred in treating HAIs.
The demand for disposable hospital supplies will increase as hospitals, outpatient care centres and other healthcare facilities adopt stricter infection prevention safeguards to meet stronger standards. For example, the European market for disposable surgical gowns and drapes has witnessed a steady growth in the past few years due to the enforcement of high standards of infection control based on the new European Union Medical Device Directive (MDD) and EU regulations.
In the U.S., the disposable hospital supplies market will be driven by an expanding patient pool and the expansion of health insurance coverage by the Affordable Care Act of 2010, which had resulted in an increased number of people seeking medical care. The increasing incidences of HAIs are a cause of concern for patients, the healthcare industry and governments.
Â
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.